
Mark J. Cziraky, PharmD, CLS, FAHA
Advertisement
Articles by Mark J. Cziraky, PharmD, CLS, FAHA
Advertisement
Latest Updated Articles
The Impact of Residual CVD Risk in the Managed Care SettingPublished: March 27th 2009 | Updated:
IntroductionPublished: March 27th 2009 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
TrumpRx Launch Brings Savings—and Uncertainty
2
As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”
3
Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP
4
Asundexian Reduces Risk of Stroke Recurrence in Phase 3 OCEANIC-STROKE Trial
5



